Related Experiment Videos
Management of chronic asthma.
1Department of Pediatrics, University of Washington, Seattle.
Pediatric Clinics of North America
|December 1, 1992
Summary
Asthma treatment now focuses on inflammation, using anti-inflammatory medicines as the main therapy for persistent symptoms. Bronchodilators are secondary for chronic asthma but vital for acute relief, alongside essential patient education for best results.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Asthma pathogenesis increasingly recognized as inflammatory.
- Shifting treatment paradigms towards anti-inflammatory strategies.
- Understanding the role of inflammation in persistent asthma symptoms.
Purpose of the Study:
- To highlight the evolving treatment of asthma.
- To emphasize the central role of anti-inflammatory medications.
- To define the appropriate use of bronchodilators in asthma management.
Main Methods:
- Review of current asthma treatment guidelines.
- Analysis of the role of inflammation in asthma.
- Evaluation of therapeutic strategies for persistent symptoms.
Main Results:
- Anti-inflammatory medicines are foundational for persistent asthma.
- Bronchodilators serve as adjuvant therapy in chronic asthma.
- Patient education is critical for treatment success.
Conclusions:
- Current asthma management prioritizes controlling airway inflammation.
- Effective asthma therapy requires a combination of anti-inflammatory drugs, appropriate bronchodilator use, and patient education.